HPV16E6 antibodies are sensitive for HPV-driven oropharyngeal cancer and associated with recurrence

BACKGROUND: HPV16E6 antibodies may be an early marker of HPV-driven oropharyngeal cancer (HPV-OPC) diagnosis and recurrence. METHODS: We identified 161 incident OPCs diagnosed at the University of Pittsburgh (2003–2013) with pre-treatment serum; 112 had pre-existing clinical HPV testing with p16 imm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Lang Kuhs, Krystle A., Kreimer, Aimée R., Trivedi, Sumita, Holzinger, Dana, Pawlita, Michael, Pfeiffer, Ruth M., Gibson, Sandra P., Schmitt, Nicole C., Hildesheim, Allan, Waterboer, Tim, Ferris, Robert L.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743332/
https://ncbi.nlm.nih.gov/pubmed/28950407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30966
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars